Simultaneous development of zanubrutinib in the USA and China

Li, GQ; Liu, XZ; Chen, XY

Chen, XY (corresponding author), Tsinghua Univ, Tsinghua Clin Res Inst, Sch Med, Beijing, Peoples R China.; Chen, XY (corresponding author), Beijing Tsinghua Changguang Hosp, Off Clin Trial Inst, Beijing, Peoples R China.

NATURE REVIEWS CLINICAL ONCOLOGY, 2020; 17 (10): 589

Abstract

Zanubrutinib was recently granted expedited approval by the USA and Chinese drug regulatory authorities for the treatment of mantle cell lymphoma, thu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索